Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 9.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2005 to 2009

Recipients with Liver Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 6,218 100.0% 23,354 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 177 2.8% 39 0.2%
OKT3 24 0.4% 58 0.2%
Thymoglobulin 1,618 26.0% 1,044 4.5%
Zenapax 690 11.1% 1,202 5.1%
Simulect 670 10.8% 1,360 5.8%
Campath 236 3.8% 124 0.5%
Rituximab 542 8.7% 31 0.1%
No Induction Drug Reported 2,863 46.0% 19,607 84.0%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.